COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 188 filers reported holding COHERUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $506,883 | -34.7% | 118,708 | +4.6% | 0.00% | -50.0% |
| Q1 2023 | $776,532 | -17.6% | 113,528 | -4.6% | 0.01% | -14.3% |
| Q4 2022 | $942,084 | +82322.0% | 118,950 | 0.0% | 0.01% | -30.0% |
| Q3 2022 | $1,143 | -99.9% | 118,950 | 0.0% | 0.01% | +42.9% |
| Q2 2022 | $861,000 | -43.9% | 118,950 | 0.0% | 0.01% | -22.2% |
| Q1 2022 | $1,536,000 | -25.9% | 118,950 | -8.4% | 0.01% | -18.2% |
| Q4 2021 | $2,072,000 | +0.5% | 129,810 | +1.2% | 0.01% | -8.3% |
| Q3 2021 | $2,061,000 | +9.4% | 128,270 | -5.8% | 0.01% | +9.1% |
| Q2 2021 | $1,884,000 | -25.2% | 136,220 | -21.0% | 0.01% | -31.2% |
| Q1 2021 | $2,520,000 | +3.4% | 172,462 | +23.0% | 0.02% | -15.8% |
| Q4 2020 | $2,437,000 | -4.6% | 140,240 | +0.7% | 0.02% | -9.5% |
| Q3 2020 | $2,554,000 | +4.9% | 139,240 | +2.2% | 0.02% | -8.7% |
| Q2 2020 | $2,434,000 | – | 136,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |